Clinical trial

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With…

NCT00022399 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00022399
Title Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Official title A Randomized, Placebo-Controlled Trial Of Celecoxib In Men Pre-Prostatectomy For Clinically Localized Adenocarcinoma Of The Prostate: Evaluation Of Drug-Specific Biomarker Modulation
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug
Interventions celecoxib, Placebos
Enrollment 73
Start date Apr 25, 2002
Primary completion Jan 31, 2005
Completion Jan 31, 2005
First posted Jan 27, 2003
Last update posted Feb 8, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies